Yttrium oxide nanoparticles prevent photoreceptor death in a light-damage model of retinal degeneration.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 4171208)

Published in Free Radic Biol Med on July 24, 2014

Authors

Rajendra N Mitra1, Miles J Merwin1, Zongchao Han1, Shannon M Conley1, Muayyad R Al-Ubaidi1, Muna I Naash2

Author Affiliations

1: Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
2: Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA. Electronic address: muna-naash@ouhsc.edu.

Articles cited by this

Molecular mechanisms of light-induced photoreceptor apoptosis and neuroprotection for retinal degeneration. Prog Retin Eye Res (2004) 3.43

Chemistry and biology of reactive oxygen species in signaling or stress responses. Nat Chem Biol (2011) 3.36

Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides. Nat Nanotechnol (2006) 3.30

Oxidative damage and protection of the RPE. Prog Retin Eye Res (2000) 2.65

Cerium and yttrium oxide nanoparticles are neuroprotective. Biochem Biophys Res Commun (2006) 2.26

Efficient non-viral ocular gene transfer with compacted DNA nanoparticles. PLoS One (2006) 1.71

Curcumin protects retinal cells from light-and oxidant stress-induced cell death. Free Radic Biol Med (2008) 1.51

Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysis. BMJ (2007) 1.46

Bioenergetic and oxidative stress in neurodegenerative diseases. Life Sci (1995) 1.43

Upregulation of thioredoxin system via Nrf2-antioxidant responsive element pathway in adaptive-retinal neuroprotection in vivo and in vitro. Free Radic Biol Med (2007) 1.42

Photoreceptor cells are major contributors to diabetes-induced oxidative stress and local inflammation in the retina. Proc Natl Acad Sci U S A (2013) 1.36

Oxygen toxicity and reactive oxygen species: the devil is in the details. Pediatr Res (2009) 1.33

Effects of different types of oxidative stress in RPE cells. J Cell Physiol (2006) 1.32

Upconverting luminescent nanomaterials: application to in vivo bioimaging. Chem Commun (Camb) (2009) 1.30

Protein modifications by 4-hydroxynonenal and 4-hydroxyhexenal in light-exposed rat retina. Invest Ophthalmol Vis Sci (2005) 1.25

Retinal light toxicity. Eye (Lond) (2010) 1.22

Neuroprotective effect of an antioxidant, lutein, during retinal inflammation. Invest Ophthalmol Vis Sci (2008) 1.21

DNA nanoparticle-mediated ABCA4 delivery rescues Stargardt dystrophy in mice. J Clin Invest (2012) 1.19

Systemic administration of the iron chelator deferiprone protects against light-induced photoreceptor degeneration in the mouse retina. Free Radic Biol Med (2012) 1.17

Retinal degeneration from oxidative damage. Free Radic Biol Med (2005) 1.17

Oxidative stress, polyunsaturated fatty acids-derived oxidation products and bisretinoids as potential inducers of CNS diseases: focus on age-related macular degeneration. Pharmacol Rep (2013) 1.09

Neuroprotective strategies for the treatment of inherited photoreceptor degeneration. Curr Mol Med (2012) 1.07

An overview of lipid peroxidation with emphasis in outer segments of photoreceptors and the chemiluminescence assay. Int J Biochem Cell Biol (2006) 1.02

Free radicals, antioxidants and eye diseases: evidence from epidemiological studies on cataract and age-related macular degeneration. Ophthalmic Res (2010) 1.00

Folate receptor targeted, rare-earth oxide nanocrystals for bi-modal fluorescence and magnetic imaging of cancer cells. Biomaterials (2009) 1.00

Altered antioxidant-oxidant status in the aqueous humor and peripheral blood of patients with retinitis pigmentosa. PLoS One (2013) 0.96

Antioxidant properties of cerium oxide nanocrystals as a function of nanocrystal diameter and surface coating. ACS Nano (2013) 0.93

Synthesis and Cytotoxicity of Y(2)O(3) Nanoparticles of Various Morphologies. Nanoscale Res Lett (2009) 0.91

Basic fibroblast growth factor-induced protection from light damage in the mouse retina in vivo. J Neurochem (2007) 0.89

Fabrication of novel luminor Y(2)O(3):Eu(3+)@SiO(2)@YVO(4):Eu(3+) with core/shell heteronanostructure. Nanotechnology (2008) 0.88

Comparison of acute oxidative stress on rat lung induced by nano and fine-scale, soluble and insoluble metal oxide particles: NiO and TiO2. Inhal Toxicol (2012) 0.86

Surface modification of Y2O3 nanoparticles. Langmuir (2007) 0.85

Antioxidants and the integrity of ocular tissues. Vet Med Int (2011) 0.84

Retinal photodamage by endogenous and xenobiotic agents. Photochem Photobiol (2012) 0.83

An activatable multimodal/multifunctional nanoprobe for direct imaging of intracellular drug delivery. Biomaterials (2011) 0.83

Antiapoptotic effects of cerium oxide and yttrium oxide nanoparticles in isolated rat pancreatic islets. Hum Exp Toxicol (2013) 0.82

Synthesis and characterization of glycol chitosan DNA nanoparticles for retinal gene delivery. ChemMedChem (2013) 0.80

A modular monolayer coating enables cell targeting by luminescent yttria nanoparticles. Bioconjug Chem (2009) 0.79

Manipulation of dopant distribution in yttrium-doped ceria particles. J Nanosci Nanotechnol (2012) 0.77

Articles by these authors

PRPH2/RDS and ROM-1: Historical context, current views and future considerations. Prog Retin Eye Res (2016) 0.77